Advertisement

Journal of General Internal Medicine

, Volume 23, Issue 10, pp 1571–1575 | Cite as

Depression and Diabetes: A Potentially Lethal Combination

  • Wayne KatonEmail author
  • Ming-Yu Fan
  • Jürgen Unützer
  • Jennifer Taylor
  • Harold Pincus
  • Michael Schoenbaum
Original Article

Abstract

Objective

To assess whether Medicare fee-for-service beneficiaries with depression and diabetes had a higher mortality rate over a 2-year period compared with beneficiaries with diabetes alone.

Design

Evidence of depression was based on a physician diagnosis or self-reported prescription of an antidepressant in the year prior to screening, or a score of ≥3 on the Patient Health Questionnaire two-item questionnaire. Mortality was assessed bi-monthly by checking Medicare claims and eligibility files or from information from telephone contact with the participant’s family. Cox proportional hazard regression models were used to calculate adjusted hazard ratios of death in depressed versus nondepressed beneficiaries with diabetes.

Participants

A total of 10,704 beneficiaries with diabetes enrolled in a disease management program were surveyed with a health assessment questionnaire and followed over a two-year period.

Main Results

Comorbid depression in Medicare beneficiaries with diabetes participating in a disease management program was associated with an increased risk for all-cause mortality over a two-year period of approximately 36% to 38%, depending on the definition of depression that was used. No significant increase in rates of cause-specific mortality from macrovascular disease were found in depressed versus nondepressed beneficiaries.

Conclusion

Among a large Medicare cohort of fee-for-service beneficiaries with diabetes, comorbid depression was associated with an increase in all-cause mortality over a two-year period. Future research will be required to determine whether the increase in mortality associated with depression is due to potential behavioral mediators (i.e., smoking, poor adherence to diet) or physiologic abnormalities (i.e., hypothalamic-pituitary axis dysregulation) associated with depression.

KEY WORDS

depression diabetes mortality 

Notes

Acknowledgements

This research has been supported by NIMH grants MH 0751590 (Unützer, Principal Investigator), and K24 MH 069741 (Katon, Principal Investigator)

Conflict of Interest

The authors do not have a conflict of interest with the information contained in this article.

References

  1. 1.
    Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54:216–26.PubMedCrossRefGoogle Scholar
  2. 2.
    Lin EH, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004;27:2154–60.PubMedCrossRefGoogle Scholar
  3. 3.
    Katon WJ, Lin EH, Russo J, et al. Cardiac risk factors in patients with diabetes mellitus and major depression. J Gen Intern Med. 2004;19:1192–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Musselman DL, Betan E, Larsen H, et al. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry. 2003;54:317–29.PubMedCrossRefGoogle Scholar
  5. 5.
    Joynt KE, Whellan DJ, O’Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry. 2003;54:248–61.PubMedCrossRefGoogle Scholar
  6. 6.
    Carney RM, Blumenthal JA, Freedland KE, et al. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med. 2005;165:1486–91.PubMedCrossRefGoogle Scholar
  7. 7.
    Carney RM, Freedland KE, Stein PK, et al. Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease. J Psychosom Res. 2007;62:463–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Vaccarino V, Johnson BD, Sheps DS, et al. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. J Am Coll Cardiol. 2007;50:2044–50.PubMedCrossRefGoogle Scholar
  9. 9.
    Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care. 2003;26:2822–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28:2668–72.PubMedCrossRefGoogle Scholar
  11. 11.
    Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care. 2005;28:1339–45.PubMedCrossRefGoogle Scholar
  12. 12.
    Zhang X, Norris SL, Gregg EW, et al. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol. 2005;161:652–60.PubMedCrossRefGoogle Scholar
  13. 13.
    Bruce DG, Davis WA, Starkstein SE, et al. A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetologia. 2005;48:2532–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Panzam G, Zabel-Langhenning R. Prognosis of diabetes mellitus in a geographically defined population. Diabetolgia. 1981;20:587–91.Google Scholar
  15. 15.
    Kroenke K, Spitzer RL, Williams JB. The patient health questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284–92.PubMedCrossRefGoogle Scholar
  16. 16.
    Pope GC, Kautter J, Ellis RP, et al. Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Financ Rev. 2004;25:119–41.PubMedGoogle Scholar
  17. 17.
    Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Cox D. Regression models and life tables. J Royal Statistical Soc (Series B). 1972;20:187–220.Google Scholar
  19. 19.
    Fox CS, Coady S, Sorlie PD, et al. Trends in cardiovascular complications of diabetes. JAMA. 2004;292:2495–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Taylor CB, Youngblood ME, Catellier D, et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry. 2005;62:792–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Jorge RE, Robinson RG, Arndt S, et al. Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry. 2003;160:1823–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Simon GE, Lin EH, Katon W, et al. Outcomes of “inadequate” antidepressant treatment. J Gen Intern Med. 1995;10:663–70.PubMedCrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2008

Authors and Affiliations

  • Wayne Katon
    • 1
  • Ming-Yu Fan
    • 1
  • Jürgen Unützer
    • 1
  • Jennifer Taylor
    • 2
  • Harold Pincus
    • 3
    • 4
  • Michael Schoenbaum
    • 5
  1. 1.Department of Psychiatry and Behavioral SciencesUniversity of Washington School of MedicineSeattleUSA
  2. 2.Green Ribbon HealthLLCTampaUSA
  3. 3.Department of Psychiatry and Irving Institute for Clinical and Translational ResearchColumbia UniversityNew YorkUSA
  4. 4.Rand CorporationPittsburghUSA
  5. 5.Division of Services and Intervention Research, National Institutes of Mental HealthEpidemiology and EconomicsBethesdaUSA

Personalised recommendations